Finance

Lists
NAV:CVE
Navco Pharmaceuticals Inc
CA$0.0050
0.00%
(0.00) 1D
Oct 28, 1:31:29ā€ÆPM GMT-5  ·   CAD
All symbols
SymbolPriceChange% Change
Generating top insights for NAV...
Mkt. cap
285.35K
Avg. vol.
806.00
Volume
0.00
52-wk high
CA$0.01
52-wk low
CA$0.00
EPS
-CA$0.00
Beta
14.27
Shares outstanding
57.07M
Mkt. cap
285.35K
Avg. vol.
806.00
Volume
0.00
52-wk high
CA$0.01
52-wk low
CA$0.00
EPS
-CA$0.00
Beta
14.27
Shares outstanding
57.07M
News stories
From web sources and news partners
About Navco Pharmaceuticals Inc
CEO-
Employees-
Founded-
HeadquartersVancouver, British Columbia, Canada
SectorHealth Care
IndustryBiotechnology
Websitenavcopharma.com
Previous reportsAll values in CAD
Loading Previous Earnings...
Revenue
Net income
All values in CAD
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Revenue
-
-
-
-
Cost of goods sold
-
-
-
-
Cost of revenue
-
-
-
-
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
34.77K
2.06K
2.95K
1.58K
Operating expense
34.77K
2.06K
2.95K
1.58K
Total operating expenses
34.77K
2.06K
2.95K
1.58K
Operating income
-34.77K
-2.06K
-2.95K
-1.58K
Other non operating income
-2.27K
-1.16K
-10.54K
-1.91K
EBT including unusual items
-39.64K
-5.83K
-16.55K
-6.82K
EBT excluding unusual items
-39.64K
-5.83K
-16.55K
-6.82K
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
-39.64K
-5.83K
-16.55K
-6.82K
Net profit margin
-
-
-
-
Earnings per share
-
-
-
-
Interest and investment income
-
-
-
-
Interest expense
-2.61K
-2.61K
-3.06K
-3.33K
Net interest expenses
-2.61K
-2.61K
-3.06K
-3.33K
Depreciation and amortization charges
-
-
-
-
EBITDA
-26.38K
-
-
-
Gain or loss from assets sale
-
-
-
-
Upcoming events
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google apps